A recent epidemiological study has shown that low plasma adiponectin levels are associated with an elevated risk of pancreatic cancer [24], therefore, this study also aimed to elucidate the effects of adiponectin on pancreatic carcinogenesis. This evidence concerns the gene ADIPOQ and familial pancreatic carcinoma.